Fig. 2From: Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinomaEstimated Kaplan-Meier overall survival (a) (p = 0.104), cancer specific survival (b) (p = 0.071), bladder recurrence-free survival (c) (p = 0.294) and contralateral carcinoma-free survival (d) (p = 0.871) curves stratified by tumor locationBack to article page